Hankook Korus Pharm Co., Ltd. announced a placement of round 8 type Bearer-bearing interest-bearing, unsecured private placement convertible bonds for gross proceeds of KRW 2,000,000,000 on March 25, 2024. The transaction included participation from new investor BNC Korea Co., Ltd. The bonds bear zero interest rate and 6% maturity rate, maturing on March 25, 2027. The bonds will be fully convertible into 444,444 common shares at an issue conversion price of KRW 4,500 per share between the period starting from April 26, 2024 and ending on February 25, 2027.

The transaction has been approved by board of directors of the company.